Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 0 | 0 | 1,352,850 | 1,349,158 | 639,194 |
| Cost of Goods | N/A | N/A | 688,125 | 683,824 | 398,104 |
| Gross Profit | N/A | N/A | 664,720 | 665,330 | 241,090 |
| Operating Expenses | 15,277 | 9,030 | 363,279 | 366,420 | 317,169 |
| Operating Income | -15,277 | -9,030 | 301,571 | 299,738 | -75,975 |
| Interest Expense | 931 | 694 | 15,876 | 1,525 | 2,073 |
| Other Income | 10 | 151 | 7,454 | 6,445 | 8,667 |
| Pre-tax Income | -16,198 | -9,573 | 293,149 | 304,658 | -69,381 |
| Income Tax | N/A | N/A | 42,470 | 42,326 | 15,854 |
| Net Income Continuous | -16,198 | -9,573 | 250,679 | 262,332 | -85,235 |
| Net Income | $-16,198 | $-9,573 | $250,679 | $262,332 | $-85,235 |
| EPS Basic Total Ops | -418.00 | -278.80 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -418.01 | -278.78 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -418.00 | -278.80 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -418.01 | -278.78 | N/A | N/A | N/A |
| EBITDA(a) | $-14,537 | $-8,637 | $336,591 | $339,688 | $-29,115 |